HBI speaks with Sneh Khemka, HBI 2022 panellist and CEO of UK-based cash plan group Simplyhealth, to hear why he thinks it is time for groups like his to step out of the shadows.
As predicted by HBI earlier this year, fast-growing German and Swiss ophthalmology group Sanoptis has sold - but to an unexpected buyer. Owner Telemos Capital has signed an agreement to sell to family-backed investment holding company Groupe Bruxelles Lambert (GBL), the same group which has also just agreed to buy a majority stake in European imaging and cancer treatment provider Affidea.
Groupe Bruxelles Lambert (“GBL”) has signed definitive agreements to acquire a majority stake in European imaging and cancer treatment provider Affidea from B-FLEXION, the private investment firm of the Switzerland-based billionaire Bertarelli family. GBL will invest up to €1bn of equity for the transaction which is its first substantive healthcare investment.
A primetime ‘exposé’ of how private equity operates in the German ophthalmology market had some of its largest operators in its crosshairs last week. We talk to the founder of Artemis Augenkliniken, who was interviewed on camera, and a specialist healthcare lawyer, for their take on hitting the headlines for the wrong reasons.
HBI catches up with Tim Clover, CEO of UK-based ophthalmic medical products specialist Rayner, ahead of his appearance as a panellist at HBI 2022. He is excited about the Covid bounceback and hot new tech, but warns new regulations will impact heavily on everyone's costs.
Multiple sources have told HBI that fast-growing German and Swiss ophthalmology group Sanoptis might be looking at a Q2 sale, but HBI understands that is not entirely correct. HBI speaks to Sanoptis CEO Volker Wendel to set the record straight.
In July 2021, Finland’s leftist parliament passed the long-awaited SOTE reform to its healthcare system, which amalgamated 309 municipal health authorities into 21 much larger ‘welfare regions’. HBI speaks to analysts and operators to find out what impact the reform is having on the for-profit sector.
Global investment firm KKR has closed a $4bn fund dedicated to health care growth equity investment opportunities primarily in Europe and North America.
Germany has a new government - and a new Federal Minister of Health in Karl Lauterbach. HBI talks to two Germany-based sources who agree he is a politician embraced more by the public than his own party, and considers what his appointment might mean for the sector.
HBI has been told that Paris based private equity firm PAI Partners and Ontario Teachers' Pension Plan Board have agreed to acquire Germany based ophthalmology network Veonet from Nordic Capital.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
